why choose us

First received: March 06, 2023

Clinical Trial: Solriamfetol and CBT-I in Patients With Insomnia Disorder

Study Status: Completed

Recruit Status: RECRUITING

Condition: Insomnia

Study Type: INTERVENTIONAL


Official Title: The Effects of Solriamfetol and CBT-I (Alone and in Combination) on Sleep Continuity, Sleepiness, Fatigue, and Performance in Patients With Insomnia Disorder

Brief Summary: Medication is FDA approved.The objective of this project is to test the efficacy of solriamfetol for treating insomnia (alone and in combination with Cognitive Behavioral Therapy for Insomnia [CBT-I]).Ultimately, this study will test whether wake extension (regardless of how it is achieved) will consolidate sleep and improve sleep continuity.

Read more